
- This event has passed.
Understanding Your Prostate Biopsy Report with Dr. Jonathan Epstein
Understanding Not Only What is Present on Your Pathology Report, But Important Information that Could be Missing or Inaccurate
In this educational session, globally renowned uropathologist, Dr. Jonathan Epstein will explain how prostate biopsy specimens are evaluated, what key findings on the pathology report mean, and why some important details may be missing or inaccurately reported. He also discusses how differences in pathology interpretation can influence grading, risk assessment, and downstream treatment decisions.
If you’ve ever felt unsure about understanding your prostate biopsy report or what questions to ask about missing details, this session will help.
This session is designed to help patients better understand their biopsy reports and feel more prepared to ask informed questions during clinical consultations—particularly for men considering or already on Active Surveillance.
JOIN THE CONVERSATION
Join us for a live educational presentation with Dr. Jonathan Epstein, one of the world’s leading experts in prostate cancer pathology, as he walks through what biopsy reports capture, what they may miss, and why accurate interpretation matters.
Saturday, January 24, 2026 • 10:00 AM Eastern Time
Patients are invited to send questions in advance to contactus@aspatients.org.
There will be dedicated time for live Q&A following the presentation.
ABOUT OUR SPEAKER

Dr. Jonathan Epstein is a globally renowned urologic pathologist recognized for his expertise in prostate and bladder cancer diagnosis. He is best known for leading the reform of the Gleason scoring system and introducing the simplified Grade Group system now used worldwide to improve clarity and prognostic accuracy for patients.
Dr. Epstein recently launched Advanced Uropathology of New York: Global Consultation Services after nearly 40 years on the faculty at Johns Hopkins University School of Medicine. Advanced Uropathology is affiliated with Integrated Medical Professionals, PLLC (IMP), a subsidiary of Solaris Health.
His work has shaped modern standards for prostate cancer grading, reporting, and clinical decision-making across the world.
Saturday, January 24, 2026 • 10:00 AM Eastern Time
Related ASPI Resources on Pathology
• Cracking the Code on Pathology Reports Webinar
• AS 101 Episode 5: Second Opinions and More with Dr. Jonathan Epstein